Mostafa Faisal, Adjunct Assistant Professor at Alfaisal University, shared a post on X:
“Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory AML (2013–2022): A retrospective study by the adult AML working group of the Japanese Society for Transplantation and Cellular Therapy
Primary Refractory AML and Allo-HCT (n=2600, Japan 2013–2022)
3-yr OS: 28.5% | LFS: 24.4%
Relapse: 49.8% | NRM: 25.8%Worse outcomes with:
– Age ≥50
– PS ≥2
– Adverse cytogenetics
– EM disease
– PB blasts ≥10%.”
Title: Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013–2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy
Authors: Takaaki Konuma, Yoshimitsu Shimomura, Shohei Mizuno, Satoshi Yamasaki, Shunsuke Yui, Naoyuki Uchida, Noriko Doki, Masatsugu Tanaka, Satoshi Yoshihara, Tetsuya Eto, Yuta Katayama, Yuna Katsuoka, Masahito Tokunaga, Shuichi Ota, Mamiko Sakata-Yanagimoto, Kazuya Ishiwata, Yoshinobu Kanda, Toshiro Kawakita, Makoto Onizuka, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Masamitsu Yanada
More posts featuring AML on OncoDaily.